All In MedTech

FDA Clearance Tracker · P070008-S062

STRATOS LV/LV-T CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRP-T) SYSTME

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 19, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 19, 2015

Approved

Time to decision

88 days

Received Mar 23, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P070008-S062
Device name
STRATOS LV/LV-T CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRP-T) SYSTME
Applicant location
Lake Oswego, OR
Received
Mar 23, 2015
Decided
Jun 19, 2015
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P070008

Device type

Device class
Class III

Every decision under product code NKE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE QP CRT-D DEVICE MODELS WITH ONE IS4 PORT, ONE IS-1 PORT AND ONE DF4 PORT ALONG WITH A UPDATED SOFTWARE PSW 1502.U FOR THE DEVICES.

Source documents

Other decisions for Biotronik, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.